Jacobs Bruce N.

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Jacobs Bruce N.'s trades of Kymera Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-04 2026-03-04 S Sale
45,659 -19.4%
425.67
US$4,108,851
45,659 -19.4% 425.67 US$4,108,851
2026-03-04 2026-03-04 S Sale
88,964 +20.1%
421.42
US$1,509,213
88,964 +20.1% 421.42 US$1,509,213
2026-03-04 2026-03-04 S Sale
50,152 +40.5%
233.86
US$2,076,253
50,152 +40.5% 233.86 US$2,076,253
2026-03-04 2026-03-04 S Sale
492 -0.2%
84.00
US$41,326
492 -0.2% 84.00 US$41,326
2026-03-04 2026-03-02 S Sale
4,113 -1.7%
89.66
US$368,761
4,113 -1.7% 89.66 US$368,761
2026-03-04 2026-03-02 S Sale
1,424 -0.6%
88.50
US$126,025
1,424 -0.6% 88.50 US$126,025
2026-03-04 2026-03-02 S Sale
2,039 -0.8%
87.75
US$178,924
2,039 -0.8% 87.75 US$178,924
2026-03-02 2026-03-02 PrS Proposed sale
12,576
90.10
US$1,133,098
12,576 90.10 US$1,133,098
2025-09-17 2025-09-17 PrS Proposed sale
79,220
48.78
US$3,864,352
79,220 48.78 US$3,864,352
2025-09-17 2025-09-17 PlS Planned sale
79,220 -25.8%
50.00
US$3,961,380
79,220 -25.8% 50.00 US$3,961,380
2025-03-03 2025-03-03 PrS Proposed sale
7,035
31.35
US$220,547
7,035 31.35 US$220,547
2025-03-03 2025-03-03 S Sale
1,281 -0.6%
31.00
US$39,717
1,281 -0.6% 31.00 US$39,717
2025-03-03 2025-03-03 S Sale
5,754 -2.8%
30.33
US$174,502
5,754 -2.8% 30.33 US$174,502
2024-03-04 2024-03-04 PrS Proposed sale
3,934
43.50
US$171,129
3,934 43.50 US$171,129
2024-03-04 2024-03-04 S Sale
255 -0.2%
43.26
US$11,030
255 -0.2% 43.26 US$11,030
2024-03-04 2024-03-04 S Sale
1,301 -0.9%
42.39
US$55,153
1,301 -0.9% 42.39 US$55,153
2024-03-04 2024-03-04 S Sale
2,378 -1.6%
41.41
US$98,481
2,378 -1.6% 41.41 US$98,481
2023-03-03 2023-03-02 PlS Planned sale
314 -0.3%
31.40
US$9,859
314 -0.3% 31.40 US$9,859
2023-03-03 2023-03-02 PlS Planned sale
1,056 -1.0%
30.88
US$32,607
1,056 -1.0% 30.88 US$32,607
2022-01-14 2022-01-12 PlS Planned sale
1,422 -7.5%
53.27
US$75,747
1,422 -7.5% 53.27 US$75,747
2022-01-14 2022-01-12 PlS Planned sale
7,151 -27.4%
52.13
US$372,788
7,151 -27.4% 52.13 US$372,788
2022-01-14 2022-01-12 PlS Planned sale
6,427 -19.8%
51.21
US$329,149
6,427 -19.8% 51.21 US$329,149
2021-12-03 2021-12-03 PlS Planned sale
300 -1.7%
55.07
US$16,520
300 -1.7% 55.07 US$16,520
2021-12-03 2021-12-03 PlS Planned sale
1,987 -10.0%
54.32
US$107,929
1,987 -10.0% 54.32 US$107,929
2021-12-03 2021-12-03 PlS Planned sale
7,713 -28.0%
53.31
US$411,188
7,713 -28.0% 53.31 US$411,188
2021-06-04 2021-06-03 PlS Planned sale
4,494 -38.2%
47.13
US$211,790
4,494 -38.2% 47.13 US$211,790
2021-06-04 2021-06-03 PlS Planned sale
5,506 -32.4%
46.66
US$256,905
5,506 -32.4% 46.66 US$256,905
2021-03-15 2021-03-15 PlS Planned sale
8,195 -100.0%
60.17
US$493,096
8,195 -100.0% 60.17 US$493,096
2021-03-15 2021-03-11 PlS Planned sale
1,805 -100.0%
60.07
US$108,432
1,805 -100.0% 60.07 US$108,432
2021-03-08 2021-03-08 PlS Planned sale
1 -100.0%
52.15
US$52
1 -100.0% 52.15 US$52
2021-03-08 2021-03-08 PlS Planned sale
2,300 -100.0%
51.28
US$117,936
2,300 -100.0% 51.28 US$117,936
2021-03-08 2021-03-08 PlS Planned sale
7,699 -77.0%
50.46
US$388,482
7,699 -77.0% 50.46 US$388,482
2021-03-05 2021-03-03 PlS Planned sale
1,100 -100.0%
45.75
US$50,323
1,100 -100.0% 45.75 US$50,323
2021-03-05 2021-03-03 PlS Planned sale
12,019 -91.6%
45.07
US$541,700
12,019 -91.6% 45.07 US$541,700
2021-03-05 2021-03-03 PlS Planned sale
6,881 -34.4%
44.12
US$303,611
6,881 -34.4% 44.12 US$303,611